Genetic Technologies (GNTLF)
OTHER OTC:GNTLF
Holding GNTLF?
Track your performance easily

Genetic Technologies (GNTLF) Financial Statements

1 Followers

Genetic Technologies Financial Overview

Genetic Technologies's market cap is currently ―. The company's EPS TTM is $-0.061; its P/E ratio is -8.16; Genetic Technologies is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Dec 22Jun 22Dec 21
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 1.04MAU$ 7.87MAU$ 5.05MAU$ 11.73MAU$ 13.51M
Total AssetsAU$ 6.19MAU$ 14.86MAU$ 15.69MAU$ 20.80MAU$ 22.54M
Total DebtAU$ 875.19KAU$ 532.85KAU$ 612.39KAU$ 652.53KAU$ 113.49K
Net DebtAU$ -164.21KAU$ -7.34MAU$ -4.43MAU$ -11.08MAU$ -13.39M
Total LiabilitiesAU$ 4.36MAU$ 3.69MAU$ 4.67MAU$ 4.37MAU$ 3.09M
Stockholders EquityAU$ 1.83MAU$ 11.16MAU$ 11.03MAU$ 16.43MAU$ 19.45M
Cash Flow-
Free Cash Flow--AU$ -2.72MAU$ 412.75KAU$ -2.23M
Operating Cash Flow-----
Investing Cash Flow--AU$ 79.45KAU$ 27.84KAU$ 32.24K
Financing Cash Flow--AU$ -166.48KAU$ 0.00AU$ -31.43K
Currency in AUD

Genetic Technologies Earnings and Revenue History

Genetic Technologies Debt to Assets

Genetic Technologies Cash Flow

Genetic Technologies Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis